Vaccine ‘may be able to delay relapse in specific pancreatic and bowel cancers’
by Nina Massey
Jan 09, 2024
2 minutes
A new vaccine has shown “promising” signs of being able to prevent relapse of specific types of pancreatic and bowel cancers for people who have previously had surgery.
Avoiding relapse could also help increase rates of survival, researchers say.
In the study, patients were given an experimental vaccine designed to target mutated KRAS – a common gene found in tumours, particularly in pancreatic and bowel (colorectal)
You’re reading a preview, subscribe to read more.
Start your free 30 days